International Journal of Biological Sciences-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2198950, encodeId=3234219895001, content=大家二审的时间是多久啊，一审给了大修more positive,修回过去20天了还是under review，好着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bc565338941, createdName=ms5000000572045221, createdTime=Wed Apr 17 13:51:38 CST 2024, time=2024-04-17, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2184609, encodeId=309e21846090d, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：前列腺癌;骨转移 经验分享：请问各位大神这个杂志proof没问题怎么确认啊？editor发的邮件里的链接只能看到PDF版本但是也没有其他确认的程序是就这样默认还是给editor回邮件确认呢？感谢回复~~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=98211616438, createdName=YYHYJ, createdTime=Mon Jan 29 11:40:16 CST 2024, time=2024-01-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2190996, encodeId=abd32190996d3, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：从23年到现在，中了2篇综述。总体上，这个期刊的难度相对容易，杂志内容水平，其实差不多是6-7分的程度，但是这个杂志有9分。国人占比很高，或许也是因为分数和实际情况不太相符+国人比例过高，在一些医院被拉黑了。9分这个档次，算比较容易, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bb45610969, createdName=ms6000001702952186, createdTime=Mon Mar 04 17:18:02 CST 2024, time=2024-03-04, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2128638, encodeId=63b12128638e6, content=04-20投稿，显示under review，目前一直有replace这个选项还没消失。等待ing, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/80079F7DA1C9AA3940C8265EFA42EC04/100, createdBy=d6b52501715, createdName=百年岐黄路, createdTime=Thu Apr 27 11:40:20 CST 2023, time=2023-04-27, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2183005, encodeId=608a218300577, content=4天replace消失，under review也不见了，10天了一直只有received，有没有好心人解答一下，祝大家都accepted!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b9675507809, createdName=ms1000001490330585, createdTime=Sun Jan 21 15:08:04 CST 2024, time=2024-01-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2199089, encodeId=d2772199089e6, content=3.13号投的，这都一个月多了，现在状态还是active under review,请问这是什么意思啊？多有才能有一修结果？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dc4d5547693, createdName=ms8000000446605296, createdTime=Thu Apr 18 10:48:22 CST 2024, time=2024-04-18, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2200145, encodeId=d4cb2200145cc, content=偏重的研究方向：分子生物学 经验分享：已接收，希望今年if保住9分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=365b5687069, createdName=ms7000001898488025, createdTime=Wed Apr 24 16:09:07 CST 2024, time=2024-04-24, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2188800, encodeId=91e62188800d0, content=replace 消失，状态从投稿完到现在一直是Received from IP This manuscript is under review. 求助大家这是送外审了吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d6fe5386329, createdName=Jojo, createdTime=Thu Feb 22 23:55:42 CST 2024, time=2024-02-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2197183, encodeId=e957219e183e3, content=偏重的研究方向：分子生物学 经验分享：请问各位大佬，大修今天返回，就在投稿这个页面，急求上传补充材料的地方，或者说是上传wb原始数据的地方在哪里呀，感谢好心人救救我呀<a href='/topic/show?id=59945501884' target=_blank style='color:#2F92EE;'>#投稿经验#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55018, encryptionId=59945501884, topicName=投稿经验)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=365b5687069, createdName=ms7000001898488025, createdTime=Sat Apr 06 20:43:47 CST 2024, time=2024-04-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2105699, encodeId=a05a2105699ff, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：炎症 经验分享：Received: 2022.10.26; Accepted: 2022.12.05; Published: 2023.01.01 动作很快，一个月不到一审结果就回来了，然后花了5天修回，10天左右就接收了，然后5天就出了proof，真是神速。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221212/08d68660ec5249d4951c3cf19104981b/d48862041d924877a2d8ff1dd10a565a.jpg, createdBy=881a5215169, createdName=1476a8ddm35暂无昵称, createdTime=Mon Dec 12 12:53:27 CST 2022, time=2022-12-12, status=1, ipAttribution=四川省)]

2024-04-17 ms5000000572045221 来自安徽省

大家二审的时间是多久啊，一审给了大修more positive,修回过去20天了还是under review，好着急

1 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2198950, encodeId=3234219895001, content=大家二审的时间是多久啊，一审给了大修more positive,修回过去20天了还是under review，好着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bc565338941, createdName=ms5000000572045221, createdTime=Wed Apr 17 13:51:38 CST 2024, time=2024-04-17, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2184609, encodeId=309e21846090d, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：前列腺癌;骨转移 经验分享：请问各位大神这个杂志proof没问题怎么确认啊？editor发的邮件里的链接只能看到PDF版本但是也没有其他确认的程序是就这样默认还是给editor回邮件确认呢？感谢回复~~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=98211616438, createdName=YYHYJ, createdTime=Mon Jan 29 11:40:16 CST 2024, time=2024-01-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2190996, encodeId=abd32190996d3, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：从23年到现在，中了2篇综述。总体上，这个期刊的难度相对容易，杂志内容水平，其实差不多是6-7分的程度，但是这个杂志有9分。国人占比很高，或许也是因为分数和实际情况不太相符+国人比例过高，在一些医院被拉黑了。9分这个档次，算比较容易, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bb45610969, createdName=ms6000001702952186, createdTime=Mon Mar 04 17:18:02 CST 2024, time=2024-03-04, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2128638, encodeId=63b12128638e6, content=04-20投稿，显示under review，目前一直有replace这个选项还没消失。等待ing, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/80079F7DA1C9AA3940C8265EFA42EC04/100, createdBy=d6b52501715, createdName=百年岐黄路, createdTime=Thu Apr 27 11:40:20 CST 2023, time=2023-04-27, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2183005, encodeId=608a218300577, content=4天replace消失，under review也不见了，10天了一直只有received，有没有好心人解答一下，祝大家都accepted!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b9675507809, createdName=ms1000001490330585, createdTime=Sun Jan 21 15:08:04 CST 2024, time=2024-01-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2199089, encodeId=d2772199089e6, content=3.13号投的，这都一个月多了，现在状态还是active under review,请问这是什么意思啊？多有才能有一修结果？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dc4d5547693, createdName=ms8000000446605296, createdTime=Thu Apr 18 10:48:22 CST 2024, time=2024-04-18, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2200145, encodeId=d4cb2200145cc, content=偏重的研究方向：分子生物学 经验分享：已接收，希望今年if保住9分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=365b5687069, createdName=ms7000001898488025, createdTime=Wed Apr 24 16:09:07 CST 2024, time=2024-04-24, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2188800, encodeId=91e62188800d0, content=replace 消失，状态从投稿完到现在一直是Received from IP This manuscript is under review. 求助大家这是送外审了吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d6fe5386329, createdName=Jojo, createdTime=Thu Feb 22 23:55:42 CST 2024, time=2024-02-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2197183, encodeId=e957219e183e3, content=偏重的研究方向：分子生物学 经验分享：请问各位大佬，大修今天返回，就在投稿这个页面，急求上传补充材料的地方，或者说是上传wb原始数据的地方在哪里呀，感谢好心人救救我呀<a href='/topic/show?id=59945501884' target=_blank style='color:#2F92EE;'>#投稿经验#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55018, encryptionId=59945501884, topicName=投稿经验)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=365b5687069, createdName=ms7000001898488025, createdTime=Sat Apr 06 20:43:47 CST 2024, time=2024-04-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2105699, encodeId=a05a2105699ff, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：炎症 经验分享：Received: 2022.10.26; Accepted: 2022.12.05; Published: 2023.01.01 动作很快，一个月不到一审结果就回来了，然后花了5天修回，10天左右就接收了，然后5天就出了proof，真是神速。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221212/08d68660ec5249d4951c3cf19104981b/d48862041d924877a2d8ff1dd10a565a.jpg, createdBy=881a5215169, createdName=1476a8ddm35暂无昵称, createdTime=Mon Dec 12 12:53:27 CST 2022, time=2022-12-12, status=1, ipAttribution=四川省)]

2024-01-29 YYHYJ 来自江苏省

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：前列腺癌;骨转移
经验分享：请问各位大神这个杂志proof没问题怎么确认啊？editor发的邮件里的链接只能看到PDF版本但是也没有其他确认的程序是就这样默认还是给editor回邮件确认呢？感谢回复~~

19 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2198950, encodeId=3234219895001, content=大家二审的时间是多久啊，一审给了大修more positive,修回过去20天了还是under review，好着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bc565338941, createdName=ms5000000572045221, createdTime=Wed Apr 17 13:51:38 CST 2024, time=2024-04-17, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2184609, encodeId=309e21846090d, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：前列腺癌;骨转移 经验分享：请问各位大神这个杂志proof没问题怎么确认啊？editor发的邮件里的链接只能看到PDF版本但是也没有其他确认的程序是就这样默认还是给editor回邮件确认呢？感谢回复~~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=98211616438, createdName=YYHYJ, createdTime=Mon Jan 29 11:40:16 CST 2024, time=2024-01-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2190996, encodeId=abd32190996d3, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：从23年到现在，中了2篇综述。总体上，这个期刊的难度相对容易，杂志内容水平，其实差不多是6-7分的程度，但是这个杂志有9分。国人占比很高，或许也是因为分数和实际情况不太相符+国人比例过高，在一些医院被拉黑了。9分这个档次，算比较容易, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bb45610969, createdName=ms6000001702952186, createdTime=Mon Mar 04 17:18:02 CST 2024, time=2024-03-04, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2128638, encodeId=63b12128638e6, content=04-20投稿，显示under review，目前一直有replace这个选项还没消失。等待ing, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/80079F7DA1C9AA3940C8265EFA42EC04/100, createdBy=d6b52501715, createdName=百年岐黄路, createdTime=Thu Apr 27 11:40:20 CST 2023, time=2023-04-27, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2183005, encodeId=608a218300577, content=4天replace消失，under review也不见了，10天了一直只有received，有没有好心人解答一下，祝大家都accepted!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b9675507809, createdName=ms1000001490330585, createdTime=Sun Jan 21 15:08:04 CST 2024, time=2024-01-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2199089, encodeId=d2772199089e6, content=3.13号投的，这都一个月多了，现在状态还是active under review,请问这是什么意思啊？多有才能有一修结果？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dc4d5547693, createdName=ms8000000446605296, createdTime=Thu Apr 18 10:48:22 CST 2024, time=2024-04-18, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2200145, encodeId=d4cb2200145cc, content=偏重的研究方向：分子生物学 经验分享：已接收，希望今年if保住9分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=365b5687069, createdName=ms7000001898488025, createdTime=Wed Apr 24 16:09:07 CST 2024, time=2024-04-24, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2188800, encodeId=91e62188800d0, content=replace 消失，状态从投稿完到现在一直是Received from IP This manuscript is under review. 求助大家这是送外审了吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d6fe5386329, createdName=Jojo, createdTime=Thu Feb 22 23:55:42 CST 2024, time=2024-02-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2197183, encodeId=e957219e183e3, content=偏重的研究方向：分子生物学 经验分享：请问各位大佬，大修今天返回，就在投稿这个页面，急求上传补充材料的地方，或者说是上传wb原始数据的地方在哪里呀，感谢好心人救救我呀<a href='/topic/show?id=59945501884' target=_blank style='color:#2F92EE;'>#投稿经验#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55018, encryptionId=59945501884, topicName=投稿经验)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=365b5687069, createdName=ms7000001898488025, createdTime=Sat Apr 06 20:43:47 CST 2024, time=2024-04-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2105699, encodeId=a05a2105699ff, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：炎症 经验分享：Received: 2022.10.26; Accepted: 2022.12.05; Published: 2023.01.01 动作很快，一个月不到一审结果就回来了，然后花了5天修回，10天左右就接收了，然后5天就出了proof，真是神速。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221212/08d68660ec5249d4951c3cf19104981b/d48862041d924877a2d8ff1dd10a565a.jpg, createdBy=881a5215169, createdName=1476a8ddm35暂无昵称, createdTime=Mon Dec 12 12:53:27 CST 2022, time=2022-12-12, status=1, ipAttribution=四川省)]

2024-03-04 ms6000001702952186 来自河南省

审稿速度:6.0 | 投稿命中率:50.0
偏重的研究方向：肿瘤
经验分享：从23年到现在，中了2篇综述。总体上，这个期刊的难度相对容易，杂志内容水平，其实差不多是6-7分的程度，但是这个杂志有9分。国人占比很高，或许也是因为分数和实际情况不太相符+国人比例过高，在一些医院被拉黑了。9分这个档次，算比较容易

22 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=2198950, encodeId=3234219895001, content=大家二审的时间是多久啊，一审给了大修more positive,修回过去20天了还是under review，好着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bc565338941, createdName=ms5000000572045221, createdTime=Wed Apr 17 13:51:38 CST 2024, time=2024-04-17, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2184609, encodeId=309e21846090d, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：前列腺癌;骨转移 经验分享：请问各位大神这个杂志proof没问题怎么确认啊？editor发的邮件里的链接只能看到PDF版本但是也没有其他确认的程序是就这样默认还是给editor回邮件确认呢？感谢回复~~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=98211616438, createdName=YYHYJ, createdTime=Mon Jan 29 11:40:16 CST 2024, time=2024-01-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2190996, encodeId=abd32190996d3, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：从23年到现在，中了2篇综述。总体上，这个期刊的难度相对容易，杂志内容水平，其实差不多是6-7分的程度，但是这个杂志有9分。国人占比很高，或许也是因为分数和实际情况不太相符+国人比例过高，在一些医院被拉黑了。9分这个档次，算比较容易, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bb45610969, createdName=ms6000001702952186, createdTime=Mon Mar 04 17:18:02 CST 2024, time=2024-03-04, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2128638, encodeId=63b12128638e6, content=04-20投稿，显示under review，目前一直有replace这个选项还没消失。等待ing, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/80079F7DA1C9AA3940C8265EFA42EC04/100, createdBy=d6b52501715, createdName=百年岐黄路, createdTime=Thu Apr 27 11:40:20 CST 2023, time=2023-04-27, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2183005, encodeId=608a218300577, content=4天replace消失，under review也不见了，10天了一直只有received，有没有好心人解答一下，祝大家都accepted!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b9675507809, createdName=ms1000001490330585, createdTime=Sun Jan 21 15:08:04 CST 2024, time=2024-01-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2199089, encodeId=d2772199089e6, content=3.13号投的，这都一个月多了，现在状态还是active under review,请问这是什么意思啊？多有才能有一修结果？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dc4d5547693, createdName=ms8000000446605296, createdTime=Thu Apr 18 10:48:22 CST 2024, time=2024-04-18, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2200145, encodeId=d4cb2200145cc, content=偏重的研究方向：分子生物学 经验分享：已接收，希望今年if保住9分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=365b5687069, createdName=ms7000001898488025, createdTime=Wed Apr 24 16:09:07 CST 2024, time=2024-04-24, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2188800, encodeId=91e62188800d0, content=replace 消失，状态从投稿完到现在一直是Received from IP This manuscript is under review. 求助大家这是送外审了吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d6fe5386329, createdName=Jojo, createdTime=Thu Feb 22 23:55:42 CST 2024, time=2024-02-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2197183, encodeId=e957219e183e3, content=偏重的研究方向：分子生物学 经验分享：请问各位大佬，大修今天返回，就在投稿这个页面，急求上传补充材料的地方，或者说是上传wb原始数据的地方在哪里呀，感谢好心人救救我呀<a href='/topic/show?id=59945501884' target=_blank style='color:#2F92EE;'>#投稿经验#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55018, encryptionId=59945501884, topicName=投稿经验)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=365b5687069, createdName=ms7000001898488025, createdTime=Sat Apr 06 20:43:47 CST 2024, time=2024-04-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2105699, encodeId=a05a2105699ff, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：炎症 经验分享：Received: 2022.10.26; Accepted: 2022.12.05; Published: 2023.01.01 动作很快，一个月不到一审结果就回来了，然后花了5天修回，10天左右就接收了，然后5天就出了proof，真是神速。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221212/08d68660ec5249d4951c3cf19104981b/d48862041d924877a2d8ff1dd10a565a.jpg, createdBy=881a5215169, createdName=1476a8ddm35暂无昵称, createdTime=Mon Dec 12 12:53:27 CST 2022, time=2022-12-12, status=1, ipAttribution=四川省)]

2023-04-27 百年岐黄路来自安徽省

04-20投稿，显示under review，目前一直有replace这个选项还没消失。等待ing

27 8

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=2198950, encodeId=3234219895001, content=大家二审的时间是多久啊，一审给了大修more positive,修回过去20天了还是under review，好着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bc565338941, createdName=ms5000000572045221, createdTime=Wed Apr 17 13:51:38 CST 2024, time=2024-04-17, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2184609, encodeId=309e21846090d, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：前列腺癌;骨转移 经验分享：请问各位大神这个杂志proof没问题怎么确认啊？editor发的邮件里的链接只能看到PDF版本但是也没有其他确认的程序是就这样默认还是给editor回邮件确认呢？感谢回复~~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=98211616438, createdName=YYHYJ, createdTime=Mon Jan 29 11:40:16 CST 2024, time=2024-01-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2190996, encodeId=abd32190996d3, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：从23年到现在，中了2篇综述。总体上，这个期刊的难度相对容易，杂志内容水平，其实差不多是6-7分的程度，但是这个杂志有9分。国人占比很高，或许也是因为分数和实际情况不太相符+国人比例过高，在一些医院被拉黑了。9分这个档次，算比较容易, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bb45610969, createdName=ms6000001702952186, createdTime=Mon Mar 04 17:18:02 CST 2024, time=2024-03-04, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2128638, encodeId=63b12128638e6, content=04-20投稿，显示under review，目前一直有replace这个选项还没消失。等待ing, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/80079F7DA1C9AA3940C8265EFA42EC04/100, createdBy=d6b52501715, createdName=百年岐黄路, createdTime=Thu Apr 27 11:40:20 CST 2023, time=2023-04-27, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2183005, encodeId=608a218300577, content=4天replace消失，under review也不见了，10天了一直只有received，有没有好心人解答一下，祝大家都accepted!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b9675507809, createdName=ms1000001490330585, createdTime=Sun Jan 21 15:08:04 CST 2024, time=2024-01-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2199089, encodeId=d2772199089e6, content=3.13号投的，这都一个月多了，现在状态还是active under review,请问这是什么意思啊？多有才能有一修结果？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dc4d5547693, createdName=ms8000000446605296, createdTime=Thu Apr 18 10:48:22 CST 2024, time=2024-04-18, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2200145, encodeId=d4cb2200145cc, content=偏重的研究方向：分子生物学 经验分享：已接收，希望今年if保住9分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=365b5687069, createdName=ms7000001898488025, createdTime=Wed Apr 24 16:09:07 CST 2024, time=2024-04-24, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2188800, encodeId=91e62188800d0, content=replace 消失，状态从投稿完到现在一直是Received from IP This manuscript is under review. 求助大家这是送外审了吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d6fe5386329, createdName=Jojo, createdTime=Thu Feb 22 23:55:42 CST 2024, time=2024-02-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2197183, encodeId=e957219e183e3, content=偏重的研究方向：分子生物学 经验分享：请问各位大佬，大修今天返回，就在投稿这个页面，急求上传补充材料的地方，或者说是上传wb原始数据的地方在哪里呀，感谢好心人救救我呀<a href='/topic/show?id=59945501884' target=_blank style='color:#2F92EE;'>#投稿经验#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55018, encryptionId=59945501884, topicName=投稿经验)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=365b5687069, createdName=ms7000001898488025, createdTime=Sat Apr 06 20:43:47 CST 2024, time=2024-04-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2105699, encodeId=a05a2105699ff, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：炎症 经验分享：Received: 2022.10.26; Accepted: 2022.12.05; Published: 2023.01.01 动作很快，一个月不到一审结果就回来了，然后花了5天修回，10天左右就接收了，然后5天就出了proof，真是神速。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221212/08d68660ec5249d4951c3cf19104981b/d48862041d924877a2d8ff1dd10a565a.jpg, createdBy=881a5215169, createdName=1476a8ddm35暂无昵称, createdTime=Mon Dec 12 12:53:27 CST 2022, time=2022-12-12, status=1, ipAttribution=四川省)]

2024-01-21 ms1000001490330585 来自广东省

4天replace消失，under review也不见了，10天了一直只有received，有没有好心人解答一下，祝大家都accepted!!!

100 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2198950, encodeId=3234219895001, content=大家二审的时间是多久啊，一审给了大修more positive,修回过去20天了还是under review，好着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bc565338941, createdName=ms5000000572045221, createdTime=Wed Apr 17 13:51:38 CST 2024, time=2024-04-17, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2184609, encodeId=309e21846090d, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：前列腺癌;骨转移 经验分享：请问各位大神这个杂志proof没问题怎么确认啊？editor发的邮件里的链接只能看到PDF版本但是也没有其他确认的程序是就这样默认还是给editor回邮件确认呢？感谢回复~~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=98211616438, createdName=YYHYJ, createdTime=Mon Jan 29 11:40:16 CST 2024, time=2024-01-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2190996, encodeId=abd32190996d3, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：从23年到现在，中了2篇综述。总体上，这个期刊的难度相对容易，杂志内容水平，其实差不多是6-7分的程度，但是这个杂志有9分。国人占比很高，或许也是因为分数和实际情况不太相符+国人比例过高，在一些医院被拉黑了。9分这个档次，算比较容易, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bb45610969, createdName=ms6000001702952186, createdTime=Mon Mar 04 17:18:02 CST 2024, time=2024-03-04, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2128638, encodeId=63b12128638e6, content=04-20投稿，显示under review，目前一直有replace这个选项还没消失。等待ing, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/80079F7DA1C9AA3940C8265EFA42EC04/100, createdBy=d6b52501715, createdName=百年岐黄路, createdTime=Thu Apr 27 11:40:20 CST 2023, time=2023-04-27, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2183005, encodeId=608a218300577, content=4天replace消失，under review也不见了，10天了一直只有received，有没有好心人解答一下，祝大家都accepted!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b9675507809, createdName=ms1000001490330585, createdTime=Sun Jan 21 15:08:04 CST 2024, time=2024-01-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2199089, encodeId=d2772199089e6, content=3.13号投的，这都一个月多了，现在状态还是active under review,请问这是什么意思啊？多有才能有一修结果？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dc4d5547693, createdName=ms8000000446605296, createdTime=Thu Apr 18 10:48:22 CST 2024, time=2024-04-18, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2200145, encodeId=d4cb2200145cc, content=偏重的研究方向：分子生物学 经验分享：已接收，希望今年if保住9分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=365b5687069, createdName=ms7000001898488025, createdTime=Wed Apr 24 16:09:07 CST 2024, time=2024-04-24, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2188800, encodeId=91e62188800d0, content=replace 消失，状态从投稿完到现在一直是Received from IP This manuscript is under review. 求助大家这是送外审了吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d6fe5386329, createdName=Jojo, createdTime=Thu Feb 22 23:55:42 CST 2024, time=2024-02-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2197183, encodeId=e957219e183e3, content=偏重的研究方向：分子生物学 经验分享：请问各位大佬，大修今天返回，就在投稿这个页面，急求上传补充材料的地方，或者说是上传wb原始数据的地方在哪里呀，感谢好心人救救我呀<a href='/topic/show?id=59945501884' target=_blank style='color:#2F92EE;'>#投稿经验#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55018, encryptionId=59945501884, topicName=投稿经验)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=365b5687069, createdName=ms7000001898488025, createdTime=Sat Apr 06 20:43:47 CST 2024, time=2024-04-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2105699, encodeId=a05a2105699ff, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：炎症 经验分享：Received: 2022.10.26; Accepted: 2022.12.05; Published: 2023.01.01 动作很快，一个月不到一审结果就回来了，然后花了5天修回，10天左右就接收了，然后5天就出了proof，真是神速。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221212/08d68660ec5249d4951c3cf19104981b/d48862041d924877a2d8ff1dd10a565a.jpg, createdBy=881a5215169, createdName=1476a8ddm35暂无昵称, createdTime=Mon Dec 12 12:53:27 CST 2022, time=2022-12-12, status=1, ipAttribution=四川省)]

2024-04-18 ms8000000446605296 来自天津

3.13号投的，这都一个月多了，现在状态还是active under review,请问这是什么意思啊？多有才能有一修结果？

10 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2198950, encodeId=3234219895001, content=大家二审的时间是多久啊，一审给了大修more positive,修回过去20天了还是under review，好着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bc565338941, createdName=ms5000000572045221, createdTime=Wed Apr 17 13:51:38 CST 2024, time=2024-04-17, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2184609, encodeId=309e21846090d, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：前列腺癌;骨转移 经验分享：请问各位大神这个杂志proof没问题怎么确认啊？editor发的邮件里的链接只能看到PDF版本但是也没有其他确认的程序是就这样默认还是给editor回邮件确认呢？感谢回复~~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=98211616438, createdName=YYHYJ, createdTime=Mon Jan 29 11:40:16 CST 2024, time=2024-01-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2190996, encodeId=abd32190996d3, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：从23年到现在，中了2篇综述。总体上，这个期刊的难度相对容易，杂志内容水平，其实差不多是6-7分的程度，但是这个杂志有9分。国人占比很高，或许也是因为分数和实际情况不太相符+国人比例过高，在一些医院被拉黑了。9分这个档次，算比较容易, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bb45610969, createdName=ms6000001702952186, createdTime=Mon Mar 04 17:18:02 CST 2024, time=2024-03-04, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2128638, encodeId=63b12128638e6, content=04-20投稿，显示under review，目前一直有replace这个选项还没消失。等待ing, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/80079F7DA1C9AA3940C8265EFA42EC04/100, createdBy=d6b52501715, createdName=百年岐黄路, createdTime=Thu Apr 27 11:40:20 CST 2023, time=2023-04-27, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2183005, encodeId=608a218300577, content=4天replace消失，under review也不见了，10天了一直只有received，有没有好心人解答一下，祝大家都accepted!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b9675507809, createdName=ms1000001490330585, createdTime=Sun Jan 21 15:08:04 CST 2024, time=2024-01-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2199089, encodeId=d2772199089e6, content=3.13号投的，这都一个月多了，现在状态还是active under review,请问这是什么意思啊？多有才能有一修结果？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dc4d5547693, createdName=ms8000000446605296, createdTime=Thu Apr 18 10:48:22 CST 2024, time=2024-04-18, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2200145, encodeId=d4cb2200145cc, content=偏重的研究方向：分子生物学 经验分享：已接收，希望今年if保住9分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=365b5687069, createdName=ms7000001898488025, createdTime=Wed Apr 24 16:09:07 CST 2024, time=2024-04-24, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2188800, encodeId=91e62188800d0, content=replace 消失，状态从投稿完到现在一直是Received from IP This manuscript is under review. 求助大家这是送外审了吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d6fe5386329, createdName=Jojo, createdTime=Thu Feb 22 23:55:42 CST 2024, time=2024-02-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2197183, encodeId=e957219e183e3, content=偏重的研究方向：分子生物学 经验分享：请问各位大佬，大修今天返回，就在投稿这个页面，急求上传补充材料的地方，或者说是上传wb原始数据的地方在哪里呀，感谢好心人救救我呀<a href='/topic/show?id=59945501884' target=_blank style='color:#2F92EE;'>#投稿经验#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55018, encryptionId=59945501884, topicName=投稿经验)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=365b5687069, createdName=ms7000001898488025, createdTime=Sat Apr 06 20:43:47 CST 2024, time=2024-04-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2105699, encodeId=a05a2105699ff, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：炎症 经验分享：Received: 2022.10.26; Accepted: 2022.12.05; Published: 2023.01.01 动作很快，一个月不到一审结果就回来了，然后花了5天修回，10天左右就接收了，然后5天就出了proof，真是神速。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221212/08d68660ec5249d4951c3cf19104981b/d48862041d924877a2d8ff1dd10a565a.jpg, createdBy=881a5215169, createdName=1476a8ddm35暂无昵称, createdTime=Mon Dec 12 12:53:27 CST 2022, time=2022-12-12, status=1, ipAttribution=四川省)]

2024-04-24 ms7000001898488025 来自北京

偏重的研究方向：分子生物学
经验分享：已接收，希望今年if保住9分

10 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2198950, encodeId=3234219895001, content=大家二审的时间是多久啊，一审给了大修more positive,修回过去20天了还是under review，好着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bc565338941, createdName=ms5000000572045221, createdTime=Wed Apr 17 13:51:38 CST 2024, time=2024-04-17, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2184609, encodeId=309e21846090d, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：前列腺癌;骨转移 经验分享：请问各位大神这个杂志proof没问题怎么确认啊？editor发的邮件里的链接只能看到PDF版本但是也没有其他确认的程序是就这样默认还是给editor回邮件确认呢？感谢回复~~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=98211616438, createdName=YYHYJ, createdTime=Mon Jan 29 11:40:16 CST 2024, time=2024-01-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2190996, encodeId=abd32190996d3, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：从23年到现在，中了2篇综述。总体上，这个期刊的难度相对容易，杂志内容水平，其实差不多是6-7分的程度，但是这个杂志有9分。国人占比很高，或许也是因为分数和实际情况不太相符+国人比例过高，在一些医院被拉黑了。9分这个档次，算比较容易, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bb45610969, createdName=ms6000001702952186, createdTime=Mon Mar 04 17:18:02 CST 2024, time=2024-03-04, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2128638, encodeId=63b12128638e6, content=04-20投稿，显示under review，目前一直有replace这个选项还没消失。等待ing, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/80079F7DA1C9AA3940C8265EFA42EC04/100, createdBy=d6b52501715, createdName=百年岐黄路, createdTime=Thu Apr 27 11:40:20 CST 2023, time=2023-04-27, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2183005, encodeId=608a218300577, content=4天replace消失，under review也不见了，10天了一直只有received，有没有好心人解答一下，祝大家都accepted!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b9675507809, createdName=ms1000001490330585, createdTime=Sun Jan 21 15:08:04 CST 2024, time=2024-01-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2199089, encodeId=d2772199089e6, content=3.13号投的，这都一个月多了，现在状态还是active under review,请问这是什么意思啊？多有才能有一修结果？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dc4d5547693, createdName=ms8000000446605296, createdTime=Thu Apr 18 10:48:22 CST 2024, time=2024-04-18, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2200145, encodeId=d4cb2200145cc, content=偏重的研究方向：分子生物学 经验分享：已接收，希望今年if保住9分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=365b5687069, createdName=ms7000001898488025, createdTime=Wed Apr 24 16:09:07 CST 2024, time=2024-04-24, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2188800, encodeId=91e62188800d0, content=replace 消失，状态从投稿完到现在一直是Received from IP This manuscript is under review. 求助大家这是送外审了吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d6fe5386329, createdName=Jojo, createdTime=Thu Feb 22 23:55:42 CST 2024, time=2024-02-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2197183, encodeId=e957219e183e3, content=偏重的研究方向：分子生物学 经验分享：请问各位大佬，大修今天返回，就在投稿这个页面，急求上传补充材料的地方，或者说是上传wb原始数据的地方在哪里呀，感谢好心人救救我呀<a href='/topic/show?id=59945501884' target=_blank style='color:#2F92EE;'>#投稿经验#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55018, encryptionId=59945501884, topicName=投稿经验)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=365b5687069, createdName=ms7000001898488025, createdTime=Sat Apr 06 20:43:47 CST 2024, time=2024-04-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2105699, encodeId=a05a2105699ff, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：炎症 经验分享：Received: 2022.10.26; Accepted: 2022.12.05; Published: 2023.01.01 动作很快，一个月不到一审结果就回来了，然后花了5天修回，10天左右就接收了，然后5天就出了proof，真是神速。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221212/08d68660ec5249d4951c3cf19104981b/d48862041d924877a2d8ff1dd10a565a.jpg, createdBy=881a5215169, createdName=1476a8ddm35暂无昵称, createdTime=Mon Dec 12 12:53:27 CST 2022, time=2022-12-12, status=1, ipAttribution=四川省)]

2024-02-22 Jojo 来自北京

replace 消失，状态从投稿完到现在一直是Received from IP This manuscript is under review. 求助大家这是送外审了吗？

18 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2198950, encodeId=3234219895001, content=大家二审的时间是多久啊，一审给了大修more positive,修回过去20天了还是under review，好着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bc565338941, createdName=ms5000000572045221, createdTime=Wed Apr 17 13:51:38 CST 2024, time=2024-04-17, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2184609, encodeId=309e21846090d, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：前列腺癌;骨转移 经验分享：请问各位大神这个杂志proof没问题怎么确认啊？editor发的邮件里的链接只能看到PDF版本但是也没有其他确认的程序是就这样默认还是给editor回邮件确认呢？感谢回复~~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=98211616438, createdName=YYHYJ, createdTime=Mon Jan 29 11:40:16 CST 2024, time=2024-01-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2190996, encodeId=abd32190996d3, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：从23年到现在，中了2篇综述。总体上，这个期刊的难度相对容易，杂志内容水平，其实差不多是6-7分的程度，但是这个杂志有9分。国人占比很高，或许也是因为分数和实际情况不太相符+国人比例过高，在一些医院被拉黑了。9分这个档次，算比较容易, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bb45610969, createdName=ms6000001702952186, createdTime=Mon Mar 04 17:18:02 CST 2024, time=2024-03-04, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2128638, encodeId=63b12128638e6, content=04-20投稿，显示under review，目前一直有replace这个选项还没消失。等待ing, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/80079F7DA1C9AA3940C8265EFA42EC04/100, createdBy=d6b52501715, createdName=百年岐黄路, createdTime=Thu Apr 27 11:40:20 CST 2023, time=2023-04-27, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2183005, encodeId=608a218300577, content=4天replace消失，under review也不见了，10天了一直只有received，有没有好心人解答一下，祝大家都accepted!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b9675507809, createdName=ms1000001490330585, createdTime=Sun Jan 21 15:08:04 CST 2024, time=2024-01-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2199089, encodeId=d2772199089e6, content=3.13号投的，这都一个月多了，现在状态还是active under review,请问这是什么意思啊？多有才能有一修结果？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dc4d5547693, createdName=ms8000000446605296, createdTime=Thu Apr 18 10:48:22 CST 2024, time=2024-04-18, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2200145, encodeId=d4cb2200145cc, content=偏重的研究方向：分子生物学 经验分享：已接收，希望今年if保住9分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=365b5687069, createdName=ms7000001898488025, createdTime=Wed Apr 24 16:09:07 CST 2024, time=2024-04-24, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2188800, encodeId=91e62188800d0, content=replace 消失，状态从投稿完到现在一直是Received from IP This manuscript is under review. 求助大家这是送外审了吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d6fe5386329, createdName=Jojo, createdTime=Thu Feb 22 23:55:42 CST 2024, time=2024-02-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2197183, encodeId=e957219e183e3, content=偏重的研究方向：分子生物学 经验分享：请问各位大佬，大修今天返回，就在投稿这个页面，急求上传补充材料的地方，或者说是上传wb原始数据的地方在哪里呀，感谢好心人救救我呀<a href='/topic/show?id=59945501884' target=_blank style='color:#2F92EE;'>#投稿经验#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55018, encryptionId=59945501884, topicName=投稿经验)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=365b5687069, createdName=ms7000001898488025, createdTime=Sat Apr 06 20:43:47 CST 2024, time=2024-04-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2105699, encodeId=a05a2105699ff, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：炎症 经验分享：Received: 2022.10.26; Accepted: 2022.12.05; Published: 2023.01.01 动作很快，一个月不到一审结果就回来了，然后花了5天修回，10天左右就接收了，然后5天就出了proof，真是神速。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221212/08d68660ec5249d4951c3cf19104981b/d48862041d924877a2d8ff1dd10a565a.jpg, createdBy=881a5215169, createdName=1476a8ddm35暂无昵称, createdTime=Mon Dec 12 12:53:27 CST 2022, time=2022-12-12, status=1, ipAttribution=四川省)]

2024-04-06 ms7000001898488025 来自北京

偏重的研究方向：分子生物学
经验分享：请问各位大佬，大修今天返回，就在投稿这个页面，急求上传补充材料的地方，或者说是上传wb原始数据的地方在哪里呀，感谢好心人救救我呀#投稿经验#

10 0

[GetPortalCommentsPageByObjectIdResponse(id=2198950, encodeId=3234219895001, content=大家二审的时间是多久啊，一审给了大修more positive,修回过去20天了还是under review，好着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bc565338941, createdName=ms5000000572045221, createdTime=Wed Apr 17 13:51:38 CST 2024, time=2024-04-17, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2184609, encodeId=309e21846090d, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：前列腺癌;骨转移 经验分享：请问各位大神这个杂志proof没问题怎么确认啊？editor发的邮件里的链接只能看到PDF版本但是也没有其他确认的程序是就这样默认还是给editor回邮件确认呢？感谢回复~~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=98211616438, createdName=YYHYJ, createdTime=Mon Jan 29 11:40:16 CST 2024, time=2024-01-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2190996, encodeId=abd32190996d3, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：从23年到现在，中了2篇综述。总体上，这个期刊的难度相对容易，杂志内容水平，其实差不多是6-7分的程度，但是这个杂志有9分。国人占比很高，或许也是因为分数和实际情况不太相符+国人比例过高，在一些医院被拉黑了。9分这个档次，算比较容易, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bb45610969, createdName=ms6000001702952186, createdTime=Mon Mar 04 17:18:02 CST 2024, time=2024-03-04, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2128638, encodeId=63b12128638e6, content=04-20投稿，显示under review，目前一直有replace这个选项还没消失。等待ing, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/80079F7DA1C9AA3940C8265EFA42EC04/100, createdBy=d6b52501715, createdName=百年岐黄路, createdTime=Thu Apr 27 11:40:20 CST 2023, time=2023-04-27, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2183005, encodeId=608a218300577, content=4天replace消失，under review也不见了，10天了一直只有received，有没有好心人解答一下，祝大家都accepted!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b9675507809, createdName=ms1000001490330585, createdTime=Sun Jan 21 15:08:04 CST 2024, time=2024-01-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2199089, encodeId=d2772199089e6, content=3.13号投的，这都一个月多了，现在状态还是active under review,请问这是什么意思啊？多有才能有一修结果？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dc4d5547693, createdName=ms8000000446605296, createdTime=Thu Apr 18 10:48:22 CST 2024, time=2024-04-18, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2200145, encodeId=d4cb2200145cc, content=偏重的研究方向：分子生物学 经验分享：已接收，希望今年if保住9分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=365b5687069, createdName=ms7000001898488025, createdTime=Wed Apr 24 16:09:07 CST 2024, time=2024-04-24, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2188800, encodeId=91e62188800d0, content=replace 消失，状态从投稿完到现在一直是Received from IP This manuscript is under review. 求助大家这是送外审了吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d6fe5386329, createdName=Jojo, createdTime=Thu Feb 22 23:55:42 CST 2024, time=2024-02-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2197183, encodeId=e957219e183e3, content=偏重的研究方向：分子生物学 经验分享：请问各位大佬，大修今天返回，就在投稿这个页面，急求上传补充材料的地方，或者说是上传wb原始数据的地方在哪里呀，感谢好心人救救我呀<a href='/topic/show?id=59945501884' target=_blank style='color:#2F92EE;'>#投稿经验#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55018, encryptionId=59945501884, topicName=投稿经验)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=365b5687069, createdName=ms7000001898488025, createdTime=Sat Apr 06 20:43:47 CST 2024, time=2024-04-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2105699, encodeId=a05a2105699ff, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：炎症 经验分享：Received: 2022.10.26; Accepted: 2022.12.05; Published: 2023.01.01 动作很快，一个月不到一审结果就回来了，然后花了5天修回，10天左右就接收了，然后5天就出了proof，真是神速。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221212/08d68660ec5249d4951c3cf19104981b/d48862041d924877a2d8ff1dd10a565a.jpg, createdBy=881a5215169, createdName=1476a8ddm35暂无昵称, createdTime=Mon Dec 12 12:53:27 CST 2022, time=2022-12-12, status=1, ipAttribution=四川省)]

2022-12-12 1476a8ddm35暂无昵称来自四川省

审稿速度:1.0 | 投稿命中率:75.0
偏重的研究方向：炎症
经验分享：Received: 2022.10.26; Accepted: 2022.12.05; Published: 2023.01.01
动作很快，一个月不到一审结果就回来了，然后花了5天修回，10天左右就接收了，然后5天就出了proof，真是神速。

61 10

展开10条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务